213 related articles for article (PubMed ID: 31528343)
1. Differences in mutational processes and intra-tumour heterogeneity between organs: The local selective filter hypothesis.
Giraudeau M; Sepp T; Ujvari B; Renaud F; Tasiemski A; Roche B; Capp JP; Thomas F
Evol Med Public Health; 2019; 2019(1):139-146. PubMed ID: 31528343
[TBL] [Abstract][Full Text] [Related]
2. Mutational heterogeneity: a key ingredient of bet-hedging and evolutionary divergence?: The broad spectrum of mutations and their flexible frequency in populations provides a source of risk avoidance and alternative evolutionary strategies.
Ferenci T; Maharjan R
Bioessays; 2015 Feb; 37(2):123-30. PubMed ID: 25370372
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Bet-hedging strategies in expanding populations.
Villa Martín P; Muñoz MA; Pigolotti S
PLoS Comput Biol; 2019 Apr; 15(4):e1006529. PubMed ID: 30998676
[TBL] [Abstract][Full Text] [Related]
5. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
[TBL] [Abstract][Full Text] [Related]
6. Hereditary cancer and its clinical implications: a view.
Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
Bignold LP
Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
[TBL] [Abstract][Full Text] [Related]
8. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
10. From developmental to atavistic bet-hedging: How cancer cells pervert the exploitation of random single-cell phenotypic fluctuations.
Capp JP; Thomas F
Bioessays; 2022 Sep; 44(9):e2200048. PubMed ID: 35839471
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma.
Gabusi A; Gissi DB; Montebugnoli L; Asioli S; Tarsitano A; Marchetti C; Balbi T; Helliwell TR; Foschini MP; Morandi L
Virchows Arch; 2020 Apr; 476(4):585-595. PubMed ID: 31468114
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity.
van den Bosch T; Derks S; Miedema DM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291770
[TBL] [Abstract][Full Text] [Related]
13. Diversity of bet-hedging strategies in microbial communities-Recent cases and insights.
Morawska LP; Hernandez-Valdes JA; Kuipers OP
WIREs Mech Dis; 2022 Mar; 14(2):e1544. PubMed ID: 35266649
[TBL] [Abstract][Full Text] [Related]
14. Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk A; Almendro V; Polyak K
Nat Rev Cancer; 2012 Apr; 12(5):323-34. PubMed ID: 22513401
[TBL] [Abstract][Full Text] [Related]
15. Many private mutations originate from the first few divisions of a human colorectal adenoma.
Kang H; Salomon MP; Sottoriva A; Zhao J; Toy M; Press MF; Curtis C; Marjoram P; Siegmund K; Shibata D
J Pathol; 2015 Nov; 237(3):355-62. PubMed ID: 26119426
[TBL] [Abstract][Full Text] [Related]
16. Oncogenesis by mutations in anti-oncogenes: a view.
Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; Derkinderen DJ; De Graaf PW; Huber J; Lips CJ; Roholl PJ
Anticancer Res; 1990; 10(2B):475-87. PubMed ID: 2190526
[TBL] [Abstract][Full Text] [Related]
17. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
18. Cancer heterogeneity: implications for targeted therapeutics.
Fisher R; Pusztai L; Swanton C
Br J Cancer; 2013 Feb; 108(3):479-85. PubMed ID: 23299535
[TBL] [Abstract][Full Text] [Related]
19. The mutator phenotype theory can explain the complex morphology and behaviour of cancers.
Bignold LP
Cell Mol Life Sci; 2002 Jun; 59(6):950-8. PubMed ID: 12169025
[TBL] [Abstract][Full Text] [Related]
20. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields.
Beyes S; Bediaga NG; Zippo A
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
